BR112015010120A2 - processo para a preparação de ácido 2-trifluorometil isonicotínico e ésteres - Google Patents
processo para a preparação de ácido 2-trifluorometil isonicotínico e ésteresInfo
- Publication number
- BR112015010120A2 BR112015010120A2 BR112015010120A BR112015010120A BR112015010120A2 BR 112015010120 A2 BR112015010120 A2 BR 112015010120A2 BR 112015010120 A BR112015010120 A BR 112015010120A BR 112015010120 A BR112015010120 A BR 112015010120A BR 112015010120 A2 BR112015010120 A2 BR 112015010120A2
- Authority
- BR
- Brazil
- Prior art keywords
- esters
- preparation
- isonicotinic acid
- trifluoromethyl isonicotinic
- trifluoromethyl
- Prior art date
Links
- BZFGKBQHQJVAHS-UHFFFAOYSA-N 2-(trifluoromethyl)pyridine-4-carboxylic acid Chemical compound OC(=O)C1=CC=NC(C(F)(F)F)=C1 BZFGKBQHQJVAHS-UHFFFAOYSA-N 0.000 title abstract 4
- 150000002148 esters Chemical class 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 3
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 abstract 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
- 239000000556 agonist Substances 0.000 abstract 1
- 239000003905 agrochemical Substances 0.000 abstract 1
- 230000006315 carbonylation Effects 0.000 abstract 1
- 238000005810 carbonylation reaction Methods 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 229910052763 palladium Inorganic materials 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/803—Processes of preparation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/84—Nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pyridine Compounds (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Catalysts (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
1/1 resumo processo para a preparação de ácido 2-trifluorometil isonicotínico e ésteres a invenção refere-se a um processo novo para a preparação de ácido 2-trifluorometil isonicotínico e ésteres da fórmula i que envolve uma carbonilação catalisada por paládio ou etapa de cianetação em que r1 é hidrogênio ou alquila q1-6. o ácido 2-trifluorometil isonicotínico e ésteres da fórmula i são intermediários versáteis para a preparação de agentes farmacêuticos e agroquímicos ativos como por exemplo, agonistas taar 1 da fórmula iii.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP12193065 | 2012-11-16 | ||
PCT/EP2013/073715 WO2014076127A1 (en) | 2012-11-16 | 2013-11-13 | Process for the preparation of 2-trifluoromethyl isonicotinic acid and esters |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112015010120A2 true BR112015010120A2 (pt) | 2017-07-11 |
Family
ID=47189790
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112015010120A BR112015010120A2 (pt) | 2012-11-16 | 2013-11-13 | processo para a preparação de ácido 2-trifluorometil isonicotínico e ésteres |
Country Status (21)
Country | Link |
---|---|
US (1) | US9481650B2 (pt) |
EP (1) | EP2920150B1 (pt) |
JP (1) | JP6267221B2 (pt) |
KR (1) | KR20150083864A (pt) |
CN (1) | CN104781236B (pt) |
AU (1) | AU2013346882B2 (pt) |
BR (1) | BR112015010120A2 (pt) |
CA (1) | CA2885155C (pt) |
ES (1) | ES2641376T3 (pt) |
HK (1) | HK1207377A1 (pt) |
HR (1) | HRP20171346T1 (pt) |
IL (1) | IL237904A (pt) |
MX (1) | MX362274B (pt) |
MY (1) | MY170491A (pt) |
NZ (1) | NZ706266A (pt) |
PL (1) | PL2920150T3 (pt) |
RU (1) | RU2654486C2 (pt) |
SG (1) | SG11201503573WA (pt) |
SI (1) | SI2920150T1 (pt) |
WO (1) | WO2014076127A1 (pt) |
ZA (1) | ZA201503201B (pt) |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4160295B2 (ja) * | 2000-12-08 | 2008-10-01 | 武田薬品工業株式会社 | 3−ピリジル基を有する置換チアゾール誘導体、その製造法および用途 |
EP1348706B1 (en) * | 2000-12-08 | 2009-08-19 | Takeda Pharmaceutical Company Limited | Substituted thiazole derivatives bearing 3-pyridyl groups, process for preparing the same and use thereof |
TW200307669A (en) * | 2002-04-15 | 2003-12-16 | Nippon Soda Co | Novel oxime o-ether compound, production process thereof, and agricultural or horticultural bactericide |
JP4972804B2 (ja) * | 2004-08-31 | 2012-07-11 | Msd株式会社 | 新規置換イミダゾール誘導体 |
US7745477B2 (en) * | 2006-02-07 | 2010-06-29 | Hoffman-La Roche Inc. | Heteroaryl and benzyl amide compounds |
WO2010100050A1 (en) | 2009-03-05 | 2010-09-10 | F. Hoffmann-La Roche Ag | Pyridine-2-yl-carboxylic acid amides |
MY160907A (en) * | 2009-11-13 | 2017-03-31 | Receptos Inc | Sphingosine 1 phosphate receptor modulators and methods of chiral synthesis |
US9132136B2 (en) * | 2010-08-02 | 2015-09-15 | Hoffmann-La Roche Inc. | Pharmaceutical combination |
JP2012106964A (ja) * | 2010-11-19 | 2012-06-07 | Ishihara Sangyo Kaisha Ltd | 2‐シクロプロピル‐6‐ハロゲノメチル‐4‐トリフルオロメチルピリジン誘導体及びその製造方法 |
AR083933A1 (es) * | 2010-11-19 | 2013-04-10 | Incyte Corp | Derivados de pirrolopiridina y pirrolopirimidina sustituidos con ciclobutilo como inhibidores de jak |
-
2013
- 2013-11-13 US US14/442,971 patent/US9481650B2/en active Active
- 2013-11-13 MX MX2015005376A patent/MX362274B/es active IP Right Grant
- 2013-11-13 NZ NZ70626613A patent/NZ706266A/en not_active IP Right Cessation
- 2013-11-13 KR KR1020157012637A patent/KR20150083864A/ko active IP Right Grant
- 2013-11-13 ES ES13792327.2T patent/ES2641376T3/es active Active
- 2013-11-13 CA CA2885155A patent/CA2885155C/en not_active Expired - Fee Related
- 2013-11-13 PL PL13792327T patent/PL2920150T3/pl unknown
- 2013-11-13 EP EP13792327.2A patent/EP2920150B1/en active Active
- 2013-11-13 RU RU2015119876A patent/RU2654486C2/ru active
- 2013-11-13 SG SG11201503573WA patent/SG11201503573WA/en unknown
- 2013-11-13 MY MYPI2015701543A patent/MY170491A/en unknown
- 2013-11-13 CN CN201380059373.XA patent/CN104781236B/zh not_active Expired - Fee Related
- 2013-11-13 AU AU2013346882A patent/AU2013346882B2/en not_active Ceased
- 2013-11-13 BR BR112015010120A patent/BR112015010120A2/pt not_active Application Discontinuation
- 2013-11-13 SI SI201330776T patent/SI2920150T1/sl unknown
- 2013-11-13 JP JP2015542256A patent/JP6267221B2/ja not_active Expired - Fee Related
- 2013-11-13 WO PCT/EP2013/073715 patent/WO2014076127A1/en active Application Filing
-
2015
- 2015-03-23 IL IL237904A patent/IL237904A/en active IP Right Grant
- 2015-05-08 ZA ZA2015/03201A patent/ZA201503201B/en unknown
- 2015-08-19 HK HK15108050.3A patent/HK1207377A1/xx not_active IP Right Cessation
-
2017
- 2017-09-06 HR HRP20171346TT patent/HRP20171346T1/hr unknown
Also Published As
Publication number | Publication date |
---|---|
AU2013346882B2 (en) | 2017-05-04 |
ZA201503201B (en) | 2016-09-28 |
JP2016500060A (ja) | 2016-01-07 |
ES2641376T3 (es) | 2017-11-08 |
SI2920150T1 (sl) | 2017-10-30 |
MX362274B (es) | 2019-01-10 |
EP2920150A1 (en) | 2015-09-23 |
KR20150083864A (ko) | 2015-07-20 |
WO2014076127A1 (en) | 2014-05-22 |
CA2885155C (en) | 2021-02-16 |
NZ706266A (en) | 2019-10-25 |
RU2015119876A (ru) | 2017-01-10 |
CA2885155A1 (en) | 2014-05-22 |
PL2920150T3 (pl) | 2017-11-30 |
MX2015005376A (es) | 2015-07-21 |
RU2654486C2 (ru) | 2018-05-21 |
CN104781236A (zh) | 2015-07-15 |
IL237904A (en) | 2017-10-31 |
AU2013346882A1 (en) | 2015-04-02 |
HRP20171346T1 (hr) | 2017-10-20 |
CN104781236B (zh) | 2018-04-24 |
EP2920150B1 (en) | 2017-07-19 |
HK1207377A1 (en) | 2016-01-29 |
SG11201503573WA (en) | 2015-06-29 |
US20150291530A1 (en) | 2015-10-15 |
MY170491A (en) | 2019-08-08 |
JP6267221B2 (ja) | 2018-01-24 |
US9481650B2 (en) | 2016-11-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112013023847A2 (pt) | composições farmacêuticas compreendendo ésteres de sorbitano | |
BR112014018756A8 (pt) | Processo para preparo de etil éster de ácido n-(4-ciclo-hexil-3-trifluorometil-benziloxi)-acetimídico | |
BR112014004219A2 (pt) | pirano[3,2-d][1,3]tiazol como inibidores de glicosidase | |
BR112013031422A2 (pt) | métodos para converter material lignocelulósico em produtos úteis | |
BR112015010649A2 (pt) | moduladores de gpr40 à base de pirrolidina | |
BR112014016185A2 (pt) | processo para a produção de uma mistura de ácido 2,4-furandicarboxílico e ácido 2,5-furandicarboxílico (fdca) por meio de reação de dismutação, mistura de 2,4-fdca e 2,5-fdca obtenível por meio desta, 2,4-fdca obtenível por meio desta e uso de 2,4-fdca | |
BR112013031307A2 (pt) | métodos para tratamento de material lignocelulósico | |
PE20142359A1 (es) | Procedimiento de preparacion de 5-fluoro-1h-pirazolopiridinas sustituidas | |
EA201492023A1 (ru) | Регуляторы пути комплемента и их применение | |
MA33948B1 (fr) | Dérivés d'acide 3-hétéroaroylamino-propionique substitues par oxygène et leur utilisation en tant qu'agents pharmaceutiques. | |
BR112013012621A2 (pt) | heterociclos microbicidas | |
TN2015000107A1 (en) | Benzamides | |
BR112014006559A2 (pt) | derivados do ácido betulínico com atividade antiviral | |
BR112014012459A2 (pt) | 2h-indazóis como antagonistas do receptor de ep2 | |
BR112014032741A2 (pt) | lipase em esterificação de ácidos graxos de cadeia curta | |
BR112014026053A2 (pt) | método de preparo de para-xileno a partir de biomassa | |
CO6321288A2 (es) | Sales de compuestos inhibidores de vih | |
CU20120064A7 (es) | Nueva asociación entre la 4-{3-[cis-hexahidrociclopenta[c]pirrol-2(1h)-il]propoxi}benzamida y un inhibidor de la acetilcolinesterasa y las composiciones farmacéuticas que la contienen | |
BR112015021990A2 (pt) | moduladores de gpr120 de ácido biciclo [2.2.1] | |
MX2014013761A (es) | Acidos (3r,4r,5s)-5-guanidino-4-acetamido-3-(pentan-3-iloxi)cicloh exen-1-carboxilicos fluorosustituidos, sus esteres y uso de los mismos. | |
BR112015007192A2 (pt) | método para produção de ácido peracético de equilíbrio e ácido peracético de equilíbrio obtenível pelo método | |
BR112014009266A8 (pt) | processos encurtado, biocatalítico e para preparação de ácidos isoxazolil-metóxi-nicotínicos | |
CU20120087A7 (es) | Procedimiento de síntesis y forma cristalina del hidrocloruro de 4-(3-(cis-hexahidrociclopenta(c)pirrol-2(1h)-il)propoxi)benzamida así como las composiciones farmacéuticas que la contienen | |
BR112015009567A2 (pt) | compostos de benzil sulfonamida novos úteis como inibidores de mogat-2 | |
BR112015010120A2 (pt) | processo para a preparação de ácido 2-trifluorometil isonicotínico e ésteres |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements |